1. Karoonkatima, M, Narongroeknawin, P, Chaiamnuay, S, Asavatanabodee, P, Pakchotanon, R. Glucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus. Int J Rheumatol. 2023;2023 :5750791. doi: 10.1155/2023/5750791. PubMed PMID:38023806 PubMed Central PMC10656199.
  2. Chitpet, P, Chaiamnuay, S, Narongroeknawin, P, Asavatanabodee, P, Leosuthamas, P, Pakchotanon, R et al.. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual. Int J Rheum Dis. 2023;26 (12):2509-2516. doi: 10.1111/1756-185X.14949. PubMed PMID:37875327 .
  3. Saisirivechakun, P, Mahakkanukrauh, A, Pongchaiyakul, C, Boonya-Ussadorn, T, Narongroeknawin, P, Pakchotanon, R et al.. Prevalence of low trabecular bone score and its association with disease severity and activity in patients with axial spondyloarthritis. Sci Rep. 2023;13 (1):16258. doi: 10.1038/s41598-023-43321-5. PubMed PMID:37758825 PubMed Central PMC10533482.
  4. Katchamart, W, Kieattisaksopon, S, Narongroeknawin, P, Muangpaisan, W, Varothai, N. Risk Factors for Sarcopenia in Thai Patients with Rheumatoid Arthritis. Discov Med. 2023;35 (176):436-443. doi: 10.24976/Discov.Med.202335176.44. PubMed PMID:37272110 .
  5. Prawjaeng, J, Leelahavarong, P, Budtarad, N, Pilasant, S, Chanjam, C, Katchamart, W et al.. Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity. BMC Health Serv Res. 2023;23 (1):561. doi: 10.1186/s12913-023-09595-1. PubMed PMID:37259090 PubMed Central PMC10230705.
  6. Leosuthamas, P, Narongroeknawin, P, Chaiamnuay, S, Asavatanabodee, P, Pakchotanon, R. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus. Int J Rheum Dis. 2023;26 (4):667-672. doi: 10.1111/1756-185X.14606. PubMed PMID:36802112 .
  7. Chaiamnuay, S, Jiemjit, S, Songdechaphipat, W, Narongroeknawin, P, Pakchotanon, R, Asavatanabodee, P et al.. Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort. Medicine (Baltimore). 2022;101 (32):e29974. doi: 10.1097/MD.0000000000029974. PubMed PMID:35960097 PubMed Central PMC9371488.
  8. Sun, X, Li, R, Cai, Y, Al-Herz, A, Lahiri, M, Choudhury, MR et al.. Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region. Lancet Reg Health West Pac. 2021;15 :100240. doi: 10.1016/j.lanwpc.2021.100240. PubMed PMID:34528015 PubMed Central PMC8365438.
  9. Katchamart, W, Narongroeknawin, P, Sukprasert, N, Chanapai, W, Srisomnuek, A. Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis. Clin Rheumatol. 2021;40 (4):1291-1298. doi: 10.1007/s10067-020-05409-5. PubMed PMID:32955630 .
  10. Phaopraphat, K, Ngamjanyaporn, P, Narongroeknawin, P, Kasitanon, N, Katchamart, W. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease. Int J Rheum Dis. 2020;23 (11):1468-1473. doi: 10.1111/1756-185X.13949. PubMed PMID:32808722 .
  11. Bupparenoo, P, Pakchotanon, R, Narongroeknawin, P, Asavatanabodee, P, Chaiamnuay, S. Effect of Curcumin on Serum Urate in Asymptomatic Hyperuricemia: A Randomized Placebo-Controlled Trial. J Diet Suppl. 2021;18 (3):248-260. doi: 10.1080/19390211.2020.1757798. PubMed PMID:32420786 .
  12. Katchamart, W, Narongroeknawin, P, Chanapai, W, Thaweeratthakul, P, Srisomnuek, A. Prevalence of and factors associated with depression and anxiety in patients with rheumatoid arthritis: A multicenter prospective cross-sectional study. Int J Rheum Dis. 2020;23 (3):302-308. doi: 10.1111/1756-185X.13781. PubMed PMID:31908153 .
  13. Katchamart, W, Narongroeknawin, P, Suppa-Udom, B, Chanapai, W, Srisomnuek, A. Factors associated with and cutoff points for Patient Acceptable Symptom State (PASS) in rheumatoid arthritis. Clin Rheumatol. 2020;39 (3):779-786. doi: 10.1007/s10067-019-04860-3. PubMed PMID:31823142 .
  14. Intongkam, S, Samakarnthai, P, Pakchotanon, R, Narongroeknawin, P, Assavatanabodee, P, Chaiamnuay, S et al.. Efficacy and Safety of Hepatitis B Vaccination in Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drugs and/or Biologics Therapy. J Clin Rheumatol. 2019;25 (8):329-334. doi: 10.1097/RHU.0000000000000877. PubMed PMID:31764493 .
  15. Ruksasakul, R, Narongroeknawin, P, Assavatanabodee, P, Chaiamnuay, S. Group B streptococcus is the most common pathogen for septic arthritis with unique clinical characteristics: data from 12 years retrospective cohort study. BMC Rheumatol. 2019;3 :38. doi: 10.1186/s41927-019-0084-5. PubMed PMID:31535078 PubMed Central PMC6745788.
  16. Yongchairat, K, Tanboon, J, Waisayarat, J, Narongroeknawin, P, Chevaisrakul, P, Dejthevaporn, C et al.. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study. Clin Rheumatol. 2019;38 (12):3459-3469. doi: 10.1007/s10067-019-04756-2. PubMed PMID:31446540 .
  17. Katchamart, W, Narongroeknawin, P, Chanapai, W, Thaweeratthakul, P. Health-related quality of life in patients with rheumatoid arthritis. BMC Rheumatol. 2019;3 :34. doi: 10.1186/s41927-019-0080-9. PubMed PMID:31428740 PubMed Central PMC6694487.
  18. Poomsalood, N, Narongroeknawin, P, Chaiamnuay, S, Asavatanabodee, P, Pakchotanon, R. Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus. Lupus. 2019;28 (10):1189-1196. doi: 10.1177/0961203319862614. PubMed PMID:31307256 .
  19. Katchamart, W, Narongroeknawin, P, Phutthinart, N, Srinonprasert, V, Muangpaisan, W, Chaiamnauy, S et al.. Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38 (7):1851-1856. doi: 10.1007/s10067-019-04488-3. PubMed PMID:30848400 .
  20. Taibanguay, N, Chaiamnuay, S, Asavatanabodee, P, Narongroeknawin, P. Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial. Patient Prefer Adherence. 2019;13 :119-129. doi: 10.2147/PPA.S192008. PubMed PMID:30666095 PubMed Central PMC6333161.
  21. Chiowchanwisawakit, P, Katchamart, W, Osiri, M, Narongroeknawin, P, Chevaisrakul, P, Kitumnuaypong, T et al.. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. J Clin Rheumatol. 2019;25 (1):9-15. doi: 10.1097/RHU.0000000000000741. PubMed PMID:29517554 .
  22. Narongroeknawin, P, Chevaisrakul, P, Kasitanon, N, Kitumnuaypong, T, Mahakkanukrauh, A, Siripaitoon, B et al.. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Int J Rheum Dis. 2018;21 (1):170-178. doi: 10.1111/1756-185X.12937. PubMed PMID:28737837 .
  23. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  24. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  25. Siricheepchaiyan, W, Narongroeknawin, P, Pakchotanon, R, Asavatanabodee, P, Chaiamnuay, S. Lupus Damage and Waist Circumference as the Independent Risk Factors for Cardiovascular Disease in SLE Patients from Phramongkutklao Hospital. J Med Assoc Thai. 2016;99 (3):290-300. . PubMed PMID:27276740 .
  26. Paosong, S, Narongroeknawin, P, Pakchotanon, R, Asavatanabodee, P, Chaiamnuay, S. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis. Int J Rheum Dis. 2015;18 (3):352-9. doi: 10.1111/1756-185X.12496. PubMed PMID:25469944 .
  27. Darawankul, B, Chaiamnuay, S, Pakchotanon, R, Asavatanabodee, P, Narongroeknawin, P. The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort. Clin Rheumatol. 2015;34 (1):43-9. doi: 10.1007/s10067-014-2749-1. PubMed PMID:25060487 .
  28. Kittiyanpanya, C, Chaiamnuay, S, Asavatanabodee, P, Narongroeknawin, P. Reliability and validity of the Thai version of bath ankylosing spondylitis indices. J Med Assoc Thai. 2014;97 (4):381-5. . PubMed PMID:24964679 .
  29. Pakchotanon, R, Chaiamnuay, S, Narongroeknawin, P, Asavatanabodee, P. The association between serum vitamin D Level and disease activity in Thai rheumatoid arthritis patients. Int J Rheum Dis. 2016;19 (4):355-61. doi: 10.1111/1756-185X.12222. PubMed PMID:24219063 .
  30. Chaiamnuay, S, Chailurkit, LO, Narongroeknawin, P, Asavatanabodee, P, Laohajaroensombat, S, Chaiamnuay, P et al.. Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus. J Clin Rheumatol. 2013;19 (3):121-5. doi: 10.1097/RHU.0b013e318289bd16. PubMed PMID:23519176 .
  31. Narongroeknawin, P, Patkar, NM, Shakoory, B, Jain, A, Curtis, JR, Delzell, E et al.. Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data. J Clin Densitom. 2012;15 (1):92-102. doi: 10.1016/j.jocd.2011.09.001. PubMed PMID:22071028 PubMed Central PMC4112756.
  32. Chaiamnuay, S, Lomaratana, V, Sumransurp, S, Phukongchai, S, Narongroeknawin, P, Asavatanabodee, P et al.. Health-related quality of life and disease severity of SLE patients in Phramongkutklao Hospital. J Med Assoc Thai. 2010;93 Suppl 6 :S125-30. . PubMed PMID:21280525 .
  33. Curtis, JR, Arora, T, Narongroeknawin, P, Taylor, A, Bingham, CO 3rd, Cush, J et al.. The delivery of evidence-based preventive care for older Americans with arthritis. Arthritis Res Ther. 2010;12 (4):R144. doi: 10.1186/ar3086. PubMed PMID:20637072 PubMed Central PMC2945038.
  34. Narongroeknawin, P, Danila, MI, Humphreys, LG Jr, Barasch, A, Curtis, JR. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist. 2010;30 (2):77-82. doi: 10.1111/j.1754-4505.2009.00128.x. PubMed PMID:20415805 PubMed Central PMC4097110.
  35. Curtis, JR, Chen, L, Harrold, LR, Narongroeknawin, P, Reed, G, Solomon, DH et al.. Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity. Arthritis Care Res (Hoboken). 2010;62 (1):101-7. doi: 10.1002/acr.20020. PubMed PMID:20191497 PubMed Central PMC2913388.
  36. Uea-areewongsa, P, Chaiamnuay, S, Narongroeknawin, P, Asavatanabodee, P. Factors associated with osteonecrosis in Thai lupus patients: a case control study. J Clin Rheumatol. 2009;15 (7):345-9. doi: 10.1097/RHU.0b013e3181ba3423. PubMed PMID:20009970 .
Search PubMed